1. Home
  2. CORT vs TFPM Comparison

CORT vs TFPM Comparison

Compare CORT & TFPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • TFPM
  • Stock Information
  • Founded
  • CORT 1998
  • TFPM 2016
  • Country
  • CORT United States
  • TFPM Canada
  • Employees
  • CORT N/A
  • TFPM N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • TFPM Precious Metals
  • Sector
  • CORT Health Care
  • TFPM Industrials
  • Exchange
  • CORT Nasdaq
  • TFPM Nasdaq
  • Market Cap
  • CORT 7.5B
  • TFPM 4.3B
  • IPO Year
  • CORT N/A
  • TFPM N/A
  • Fundamental
  • Price
  • CORT $71.72
  • TFPM $23.60
  • Analyst Decision
  • CORT Strong Buy
  • TFPM Strong Buy
  • Analyst Count
  • CORT 4
  • TFPM 3
  • Target Price
  • CORT $142.00
  • TFPM $23.67
  • AVG Volume (30 Days)
  • CORT 1.6M
  • TFPM 458.3K
  • Earning Date
  • CORT 07-28-2025
  • TFPM 08-06-2025
  • Dividend Yield
  • CORT N/A
  • TFPM 0.93%
  • EPS Growth
  • CORT 8.36
  • TFPM N/A
  • EPS
  • CORT 1.14
  • TFPM 0.02
  • Revenue
  • CORT $685,446,000.00
  • TFPM $293,708,000.00
  • Revenue This Year
  • CORT $35.83
  • TFPM $19.66
  • Revenue Next Year
  • CORT $35.24
  • TFPM $0.85
  • P/E Ratio
  • CORT $62.92
  • TFPM $947.49
  • Revenue Growth
  • CORT 30.93
  • TFPM 39.01
  • 52 Week Low
  • CORT $30.77
  • TFPM $13.94
  • 52 Week High
  • CORT $117.33
  • TFPM $25.45
  • Technical
  • Relative Strength Index (RSI)
  • CORT 50.50
  • TFPM 50.51
  • Support Level
  • CORT $66.49
  • TFPM $22.82
  • Resistance Level
  • CORT $72.49
  • TFPM $23.91
  • Average True Range (ATR)
  • CORT 2.85
  • TFPM 0.73
  • MACD
  • CORT -0.09
  • TFPM -0.18
  • Stochastic Oscillator
  • CORT 49.95
  • TFPM 30.12

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About TFPM Triple Flag Precious Metals Corp.

Triple Flag Precious Metals Corp is a streaming and royalty company focused on precious metals. Its revenues are largely generated from a diversified portfolio of properties in Australia, Canada, Colombia, Cote d'Ivoire, Mexico, Mongolia, Peru, South Africa, and the United States. Its diversified portfolio of streams and royalties comprises long-life mining assets, including the Northparkes copper-gold mine in Australia, the Cerro Lindo polymetallic mine in Peru, the Fosterville gold mine in Australia, the Buritica gold mine in Colombia, and the Impala Bafokeng Operations in South Africa among others. A majority of its revenue is derived through its interests in various gold streams. Geographically, the company derives maximum revenue from Australia, followed by Peru and other regions.

Share on Social Networks: